ASCVD Clinical Trial - Comparison of Low-Intensity Statin Plus Ezetimibe

Status Recruiting

Clinical Trial Summary

This study is to evaluating the impact of low-intensity statin plus ezetimibe versus high-intensity statin therapy on risk of new-onset diabetes mellitus in patients with atherosclerotic cardiovascular disease who have prediabetes.

Clinical Trial Description

The PROVE-DM trial is a multi-center, open-labeled, randomized controlled trial comparing two different lipid lowering strategies in patients with prediabetes and established atherosclerosis. Patients with prediabetes and documented atherosclerosis, either clinical or unequivocal on imaging are eligible for enrollment. The detailed information for inclusion and exclusion criteria is described below in the session 4. Patients meeting inclusion criteria without any exclusion criteria are assessed to be able to tolerate high-intensity statin therapy while achieving the target LDL level (LDL cholesterol < 70 mg/dL for established atherosclerotic cardiovascular disease or LDL cholesterol < 100 mg/dL for mild to moderate coronary artery disease) through a run-in period of 2 to 6 months. (Run in period was set as a screening process to reduce drop-out cases that cannot withstand high-intensity statins or cannot accomplished target LDL levels) Eligible patients will be randomized to high-intensity statin (rosuvastatin 20 mg qd) or low-intensity statin plus ezetimibe (rosuvastatin/ezetimibe 5/10 mg qd). Patients will be followed-up clinically at 6, 12 months and then annually up to 3 years after randomization. Follow-up measurement of DM diagnostic criteria (fasting plasma glucose, plasma Hb A1c, oral glucose tolerance test) and lipid profile is intended to 1) provide evidence of new onset DM, 2) evaluate effectiveness of lowering LDL cholesterol. To ensure the accurate assessment of the clinical outcomes, cardiovascular safety end point (death from cardiovascular causes, non-fatal myocardial infarction, or non-fatal stroke), any arterial revascularization, any potential side effects of statin and all-cause mortality were also investigated. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05579626
Study type	Interventional
Source	Asan Medical Center
Contact	Su-Bin Shin, RN
Phone	8272577718
Email	tls7718@naver.com
Status	Recruiting
Phase	N/A
Start date	March 14, 2023
Completion date	December 30, 2027

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05052918` - The Effect of Exercise and Metformin on Carotid Intima-media Thickness in Patients With Prediabetes	N/A
Completed	`NCT03714646` - Beta Glucan and Acetate Production	N/A
Completed	`NCT03377244` - Healthy Body Healthy Souls in the Marshallese Population	N/A
Completed	`NCT04427982` - Dance and Diabetes/Prediabetes Self-Management	N/A
Recruiting	`NCT05008276` - Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Completed	`NCT03480022` - Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS	Phase 3
Withdrawn	`NCT05726409` - Mobile Application to Create Healthy Food Preparation Habits for Patients With Diabetes and Prediabetes	N/A
Completed	`NCT02834078` - Effect of BGG on Glucose Metabolism and Other Markers of Metabolic Syndrome	N/A
Completed	`NCT04902326` - Behavioral Economics and Self-Determination Theory to Change Diabetes Risk (BEST Change)	N/A
Recruiting	`NCT04168372` - Fructose: Substrate, Stimulus, or Both?	N/A
Completed	`NCT03272074` - Egg Consumption and Glycemic Control in Individuals With Pre- and Type II-diabetes	N/A
Not yet recruiting	`NCT05939349` - A Prescription for Health Equity: A Healthcare Provider-based Produce Prescription Program for People With Prediabetes and Type 2 Diabetes	N/A
Completed	`NCT04978376` - TRE With Physical Activity for Weight Management	N/A
Recruiting	`NCT03997656` - A Digital Therapy for Diabetes Prevention Among Overweight Adults in Terengganu, Malaysia	N/A
Recruiting	`NCT05166785` - BRInging the Diabetes Prevention Program to GEriatric Populations	N/A
Completed	`NCT01729078` - Dietary Interventions in Prediabetes	N/A
Completed	`NCT04507685` - Asian Indian Prediabetes Study	N/A
Completed	`NCT03292315` - Once Weekly GLP-1 in Persons With Spinal Cord Injury	Phase 4
Active, not recruiting	`NCT05353790` - Dietary Exchanges With Avocado and Mango in Pre-diabetes	N/A
Active, not recruiting	`NCT03804892` - Can Brisk Walking Combined With Ingestion of a Lipid-lowering Drug Improve Fat Metabolism in Muscle?	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms